ArticleHaematologica2017

Targeting the 5T4 oncofetal glycoprotein with an antibody drug conjugate (A1mcMMAF) improves survival in patient-derived xenograft models of acute lymphoblastic leukemia.

Owen J McGinn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.